Research Article

You have full text access to this OnlineOpen article

Steroid injection for osteoarthritis of the hip: A randomized, double-blind, placebo-controlled trial

  1. Robert G. W. Lambert*,
  2. Edna J. Hutchings,
  3. Michael G. A. Grace,
  4. Gian S. Jhangri,
  5. Barbara Conner-Spady,
  6. Walter P. Maksymowych

Article first published online: 28 JUN 2007

DOI: 10.1002/art.22739

Issue

Arthritis & Rheumatism

Arthritis & Rheumatism

Volume 56, Issue 7, pages 2278–2287, July 2007

Additional Information

How to Cite

Lambert, R. G. W., Hutchings, E. J., Grace, M. G. A., Jhangri, G. S., Conner-Spady, B. and Maksymowych, W. P. (2007), Steroid injection for osteoarthritis of the hip: A randomized, double-blind, placebo-controlled trial. Arthritis & Rheumatism, 56: 2278–2287. doi: 10.1002/art.22739

Author Information

  1. University of Alberta, Edmonton, Alberta, Canada

*University of Alberta, Department of Radiology and Diagnostic Imaging, 2A2.41 Walter C. Mackenzie Centre, 8440 112th Street, Edmonton, Alberta T6G 2B7, Canada

Publication History

  1. Issue published online: 28 JUN 2007
  2. Article first published online: 28 JUN 2007
  3. Manuscript Accepted: 3 APR 2007
  4. Manuscript Received: 3 JAN 2007

Funded by

  • CHAR/Nycomed Development Award
  • MSI Foundation
  • University of Alberta Hospital Foundation
  • Arthritis Society of Canada
  • Alberta Heritage Foundation for Medical Research

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (175K)

REFERENCES

  • 1
    Ingvarsson T, Hagglund G, Lohmander LS. Prevalence of hip osteoarthritis in Iceland. Ann Rheum Dis 1999; 58: 201–7.
  • 2
    Lowman EW. Osteoarthritis. J Am Med Assoc 1955; 157: 487–8.
  • 3
    Helmick CG, Pollard RA, Jordan JM, Renner JB, Fryer JG, Hochberg MC. Evidence for underreading of radiographic osteoarthritis of the hips and knees in the first National Health and Nutrition Examination Survey (NHANES I) [abstract]. Arthritis Rheum 1994; 37 Suppl 9: S301.
  • 4
    Tepper S, Hochberg MC. Factors associated with hip osteoarthritis: data from the First National Health and Nutrition Examination Survey (NHANES-I). Am J Epidemiol 1993; 137: 1081–8.
  • 5
    Gabriel SE, Crowson CS, Campion ME, O'Fallon WM. Direct medical costs unique to people with arthritis. J Rheumatol 1997; 24: 719–25.
  • 6
    Flanagan J, Casale FF, Thomas TL, Desai KB. Intra-articular injection for pain relief in patients awaiting hip replacement. Ann R Coll Surg Engl 1988; 70: 156–7.
  • 7
    Kullenberg B, Runesson R, Tuvhag R, Olsson C, Resch S. Intraarticular corticosteroid injection: pain relief in osteoarthritis of the hip? J Rheumatol 2004; 31: 2265–8.
  • 8
    Qvistgaard E, Christensen R, Torp-Pedersen S, Bliddal H. Intra-articular treatment of hip osteoarthritis: a randomized trial of hyaluronic acid, corticosteroid, and isotonic saline. Osteoarthritis Cartilage 2006; 14: 163–70.
  • 9
    Hochberg MC, Altman RD, Brandt KD, Clark BM, Dieppe PA, Griffin MR, et al. Guidelines for the medical management of osteoarthritis. Part II. Osteoarthritis of the knee. Arthritis Rheum 1995; 38: 1541–6.
    Direct Link:
  • 10
    Hochberg MC, Altman RD, Brandt KD, Clark BM, Dieppe PA, Griffin MR, et al. Guidelines for the medical management of osteoarthritis. Part I. Osteoarthritis of the hip. Arthritis Rheum 1995; 38: 1535–40.
    Direct Link:
  • 11
    Jones A, Regan M, Ledingham J, Pattrick M, Manhire A, Doherty M. Importance of placement of intra-articular steroid injections. BMJ 1993; 307: 1329–30.
  • 12
    Neustadt DH. Local steroid injections: comment on the American College of Rheumatology guidelines for the management of osteoarthritis of the hip and on the letter by Swezey [letter]. Arthritis Rheum 1997; 40: 1914–5.
  • 13
    Zhang W, Doherty M, Arden N, Bannwarth B, Bijlsma J, Gunther KP, et al. EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 2005; 64: 669–81.
  • 14
    Altman R, Alarcon G, Appelrouth D, Bloch D, Borenstein D, Brandt K, et al. The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hip. Arthritis Rheum 1991; 34: 505–14.
    Direct Link:
  • 15
    Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol 1988; 15: 1833–40.
  • 16
    Derendorf H, Mollmann H, Gruner A, Haack D, Gyselby G. Pharmacokinetics and pharmacodynamics of glucocorticoid suspensions after intra-articular administration. Clin Pharmacol Ther 1986; 39: 313–7.
  • 17
    Valtonen EJ. Clinical comparison of triamcinolone hexacetonide and betamethasone in the treatment of osteoarthrosis of the knee-joint. Scand J Rheumatol Suppl 1981; 41: 1–7.
  • 18
    Crawford RW, Gie GA, Ling RS, Murray DW. Diagnostic value of intra-articular anaesthetic in primary osteoarthritis of the hip. J Bone Joint Surg Br 1998; 80: 279–81.
  • 19
    Miller JH, White J, Norton TH. The value of intra-articular injections in osteoarthritis of the knee. J Bone Joint Surg Br 1958; 40-B: 636–43.
  • 20
    Ware JE Jr, Sherbourne CD. The MOS 36-item Short-Form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992; 30: 473–83.
  • 21
    Pham T, van der Heijde D, Lassere M, Altman RD, Anderson JJ, Bellamy N, et al. Outcome variables for osteoarthritis clinical trials: the OMERACT-OARSI set of responder criteria. J Rheumatol 2003; 30: 1648–54.
  • 22
    Kellgren JH, Lawrence JS. Radiological assessment of osteo-arthrosis. Ann Rheum Dis 1957; 16: 494–502.
  • 23
    Tubach F, Ravaud P, Baron G, Falissard B, Logeart I, Bellamy N, et al. Evaluation of clinically relevant changes in patient reported outcomes in knee and hip osteoarthritis: the minimal clinically important improvement. Ann Rheum Dis 2005; 64: 29–33.
  • 24
    Chakravarty K, Pharoah PD, Scott DG. A randomized controlled study of post-injection rest following intra-articular steroid therapy for knee synovitis. Br J Rheumatol 1994; 33: 464–8.
  • 25
    Firestein GS, Paine MM, Littman BH. Gene expression (collagenase, tissue inhibitor of metalloproteinases, complement, and HLA–DR) in rheumatoid arthritis and osteoarthritis synovium: quantitative analysis and effect of intraarticular corticosteroids. Arthritis Rheum 1991; 34: 1094–105.
    Direct Link:
  • 26
    Pelletier JP, DiBattista JA, Raynauld JP, Wilhelm S, Martel-Pelletier J. The in vivo effects of intraarticular corticosteroid injections on cartilage lesions, stromelysin, interleukin-1, and oncogene protein synthesis in experimental osteoarthritis. Lab Invest 1995; 72: 578–86.
  • 27
    Saxne T, Heinegard D, Wollheim FA. Therapeutic effects on cartilage metabolism in arthritis as measured by release of proteoglycan structures into the synovial fluid. Ann Rheum Dis 1986; 45: 491–7.
  • 28
    Williams JM, Brandt KD. Triamcinolone hexacetonide protects against fibrillation and osteophyte formation following chemically induced articular cartilage damage. Arthritis Rheum 1985; 28: 1267–74.
    Direct Link:
  • 29
    Armstrong RD, English J, Gibson T, Chakraborty J, Marks V. Serum methylprednisolone levels following intra-articular injection of methylprednisolone acetate. Ann Rheum Dis 1981; 40: 571–4.
  • 30
    Gray RG, Tenenbaum J, Gottlieb NL. Local corticosteroid injection treatment in rheumatic disorders. Semin Arthritis Rheum 1981; 10: 231–54.
View Full Article (HTML) Get PDF (175K)